Suppr超能文献

影响维持性血液透析患者肌肉量减少的危险因素。

Risk Factors Affecting Muscle Mass Decline in Maintenance Hemodialysis Patients.

机构信息

Division of Nephrology, National Clinical Research Center for Aging and Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.

出版信息

Biomed Res Int. 2022 Dec 20;2022:2925216. doi: 10.1155/2022/2925216. eCollection 2022.

Abstract

OBJECTIVE

There is a high prevalence of sarcopenia in maintenance hemodialysis (MHD) patients, which is known to be associated with increased mortality. This study is aimed at analyzing the risk factors affecting muscle mass decline in MHD patients.

METHODS

This retrospective study included MHD patients who underwent two body composition assessments in October 2013 and November 2017. Depending on whether there was muscle loss or not, the patients were divided into a normal muscle mass (NMM) group and a muscle mass decline (MMD) group. According to the muscle mass decline rate, patients in the MMD group were further classified into a low-rate group and a high-rate group. Biochemical variables, serum vitamin concentrations, anthropometric data, SGA, muscle mass, handgrip, and daily steps were assessed. Risk factors for muscle mass decline were screened by multivariate logistic analysis and linear regression analysis.

RESULTS

Of the 72 MHD patients included in this study, 33 were male and 39 were female with a mean age of 56.80 ± 10.86 years and a mean dialysis duration of 7.50 ± 5.20 years. Age ( = .014) and serum 25(OH)D ( = .040) were found to be associated with a higher risk of muscle mass decline after adjusting for gender, dialysis vintage, albumin, and hs-CRP ( = .040). Further analysis found that dialysis vintage ( = 0.285, = .030), 25(OH)D ( = -0.351, = .007), and log NT-proBNP ( = 0.312, = .020) were risk factors associated with the muscle mass decline rate in MHD patients.

CONCLUSION

Age and serum 25(OH)D were associated with a higher risk of muscle mass decline, while 25(OH)D, dialysis vintage, and NT-proBNP were associated with the muscle mass decline rate in MHD patients.

摘要

目的

维持性血液透析(MHD)患者中肌少症的患病率很高,已知其与死亡率增加有关。本研究旨在分析影响 MHD 患者肌肉质量下降的危险因素。

方法

这是一项回顾性研究,纳入了 2013 年 10 月和 2017 年 11 月接受两次身体成分评估的 MHD 患者。根据是否存在肌肉损失,患者被分为正常肌肉量(NMM)组和肌肉量下降(MMD)组。根据肌肉量下降率,MMD 组患者进一步分为低速率组和高速率组。评估生化变量、血清维生素浓度、人体测量数据、SGA、肌肉量、握力和每日步数。通过多变量逻辑分析和线性回归分析筛选肌肉量下降的危险因素。

结果

本研究纳入的 72 名 MHD 患者中,男性 33 名,女性 39 名,平均年龄为 56.80 ± 10.86 岁,透析时间平均为 7.50 ± 5.20 年。调整性别、透析年限、白蛋白和 hs-CRP 后,年龄( =.014)和血清 25(OH)D( =.040)与肌肉量下降风险较高相关( =.040)。进一步分析发现,透析年限( = 0.285, =.030)、25(OH)D( = -0.351, =.007)和 log NT-proBNP( = 0.312, =.020)是与 MHD 患者肌肉量下降率相关的危险因素。

结论

年龄和血清 25(OH)D 与肌肉量下降风险较高相关,而 25(OH)D、透析年限和 NT-proBNP 与 MHD 患者肌肉量下降率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caae/9794426/9ea1d665a709/BMRI2022-2925216.001.jpg

相似文献

1
Risk Factors Affecting Muscle Mass Decline in Maintenance Hemodialysis Patients.
Biomed Res Int. 2022 Dec 20;2022:2925216. doi: 10.1155/2022/2925216. eCollection 2022.
2
Prevalence and risk factors of sarcopenia in patients on maintenance hemodialysis: a retrospective cohort study.
BMC Musculoskelet Disord. 2024 May 31;25(1):424. doi: 10.1186/s12891-024-07546-3.
3
[Association between sarcopenia and abdominal aortic calcification in maintenance hemodialysis patients].
Zhonghua Yi Xue Za Zhi. 2023 Oct 17;103(38):3026-3032. doi: 10.3760/cma.j.cn112137-20230615-01019.
4
Risk factors for decreased upper-limb muscle strength and its impact on survival in maintenance hemodialysis patients.
Int Urol Nephrol. 2020 Jun;52(6):1143-1153. doi: 10.1007/s11255-020-02468-0. Epub 2020 May 4.
6
The association between blood nickel level and handgrip strength in patients undergoing maintenance hemodialysis.
Int Urol Nephrol. 2024 Apr;56(4):1487-1495. doi: 10.1007/s11255-023-03836-2. Epub 2023 Oct 18.
7
Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk.
Ren Fail. 2016;38(3):364-71. doi: 10.3109/0886022X.2015.1132173. Epub 2016 Jan 7.
10

引用本文的文献

本文引用的文献

1
Impact of sarcopenia and its diagnostic criteria on hospitalization and mortality in chronic hemodialysis patients: A 3-year longitudinal study.
J Formos Med Assoc. 2020 Jul;119(7):1219-1229. doi: 10.1016/j.jfma.2019.10.020. Epub 2019 Nov 16.
2
Mechanisms of vitamin D action in skeletal muscle.
Nutr Res Rev. 2019 Dec;32(2):192-204. doi: 10.1017/S0954422419000064. Epub 2019 Jun 17.
3
The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis.
PLoS One. 2019 Feb 13;14(2):e0211988. doi: 10.1371/journal.pone.0211988. eCollection 2019.
4
Bioelectrical Impedance Analysis Measures and Clinical Outcomes in CKD.
Am J Kidney Dis. 2018 Nov;72(5):662-672. doi: 10.1053/j.ajkd.2018.03.030. Epub 2018 Jun 6.
5
Vitamin B12 deficiency might be related to sarcopenia in older adults.
Exp Gerontol. 2017 Sep;95:136-140. doi: 10.1016/j.exger.2017.05.017. Epub 2017 May 23.
6
Measurement of muscle mass in sarcopenia: from imaging to biochemical markers.
Aging Clin Exp Res. 2017 Feb;29(1):19-27. doi: 10.1007/s40520-016-0717-0. Epub 2017 Feb 7.
7
N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.
PLoS One. 2016 Nov 21;11(11):e0166804. doi: 10.1371/journal.pone.0166804. eCollection 2016.
8
The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients.
Clin Nutr. 2017 Dec;36(6):1654-1660. doi: 10.1016/j.clnu.2016.10.016. Epub 2016 Oct 22.
9
Lower thigh muscle mass is associated with all-cause and cardiovascular mortality in elderly hemodialysis patients.
Eur J Clin Nutr. 2017 Jan;71(1):64-69. doi: 10.1038/ejcn.2016.186. Epub 2016 Oct 19.
10
Vitamin B12 supplementation in end stage renal diseases: a systematic review.
Med J Islam Repub Iran. 2015 Jan 27;29:167. eCollection 2015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验